Precigen, Inc. (PGEN) Estados Financieros e Histórico

Precigen, Inc. (PGEN) — Precio $7.43 HealthcareBiotechnology — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de Precigen, Inc. (PGEN): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

Precigen, Inc. registró ingresos de $9.7M en el último ejercicio fiscal, con un CAGR de 5 años del -21.3%.

Cuenta de Resultados (10 años)

Año2016201720182019202020212022202320242025
Ingresos$190.9M$231.0M$160.6M$32.0M$32.0M$14.3M$26.9M$6.2M$3.9M$9.7M
Coste de Ventas$61.6M$62.8M$63.3M$5.4M$44.8M$53.7M$6.3M$6.1M$4.3M$6.1M
Beneficio Bruto$129.3M$168.2M$97.3M$26.6M-$12.8M-$39.4M$20.6M$106000-$342000$3.6M
I+D$112.1M$143.2M$404.6M$39.4M$39.4M$47.9M$47.2M$48.6M$53.1M$40.1M
Generales y Administrativos$142.3M$146.1M$137.8M$72.7M00$48.0M$40.4M$41.3M$70.1M
Gastos Operativos$254.5M$289.3M$542.4M$112.9M$73.5M$52.5M$96.3M$99.9M$134.7M$110.2M
Beneficio Operativo-$125.2M-$137.9M-$505.6M-$86.3M-$86.3M-$91.9M-$75.7M-$99.8M-$135.0M-$106.6M
EBITDA-$168.7M-$97.9M-$349.1M-$68.8M-$68.0M-$77.6M-$62.4M-$89.2M-$123.5M-$243.6M
Gastos por Intereses$861000$611000$8.5M$18.2M$18.4M$18.8M$6.8M$468000$6000$3.9M
Beneficio Antes de Impuestos-$194.2M-$129.7M-$536.2M-$104.5M-$104.5M-$111.0M-$80.0M-$96.4M-$128.0M-$250.6M
Impuestos-$3.9M-$2.9M-$21.5M-$82000-$82000-$160000-$189000-$458000-$1.8M$3000
Beneficio Neto-$186.6M-$117.0M-$509.3M-$170.5M-$170.5M-$92.2M$28.3M-$95.9M-$126.2M-$250.6M
BPA$-1.58$-0.98$-3.93$-1.35$-1.02$-0.47$-0.33$-0.39$-0.47$-1.41
BPA Diluido$-1.58$-0.98$-3.93$-1.35$-1.02$-0.47$-0.40$-0.39$-0.47$-1.41
Acciones en Circulación (Diluidas)$118.0M$120.0M$129.5M$154.1M$167.1M$197.8M$200.4M$244.5M$267.7M$304.7M

Cuenta de Resultados (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Ingresos$2.9M$4.6M$23.3M$55.0M
Beneficio Bruto$1.6M$2.7M$20.4M$52.2M
Beneficio Operativo-$34.5M-$21.7M-$6.0M$22.6M
EBITDA-$144.6M-$19.4M-$3.9M$23.0M
Beneficio Neto-$146.3M-$23.5M-$7.9M$20.1M
BPA$-1.10$-0.07$-0.03$0.06
BPA Diluido$-1.10$-0.07$-0.03$0.05

Balance (10 años)

Año2016201720182019202020212022202320242025
Caja y Equivalentes$62.6M$68.1M$102.8M$65.8M$51.8M$36.4M$4.9M$7.6M$29.5M$30.2M
Inversiones a Corto$174.6M$11.6M$120.1M$9.3M$48.3M$72.2M$51.1M$55.3M$68.4M$67.6M
Cuentas por Cobrar$42.5M$39.8M$26.6M$26.2M$20.4M$2.0M$13.8M$1.6M$1.2M$4.4M
Inventario$21.1M$20.5M$21.4M$16.1M$11.4M$326000$28700000$9.6M
Activos Corrientes$315.2M$154.0M$285.5M$234.6M$148.9M$156.6M$118.2M$68.8M$102.4M$115.2M
Inmovilizado Material$64.7M$112.7M$128.9M$86.2M$44.3M$18.6M$15.3M$14.1M$18.8M$18.4M
Fondo de Comercio$157.2M$153.3M$149.6M$63.8M$54.4M$37.6M$36.9M$26.6M$19.1M$15.2M
Activos Intangibles$225.6M$232.9M$129.3M$68.3M$65.4M$52.3M$44.5M$40.7M$4.5M$3.2M
Activos Totales$949.1M$846.9M$716.2M$455.8M$314.6M$359.9M$216.0M$151.0M$145.3M$156.6M
Cuentas por Pagar$8.5M$8.7M$12.0M$5.5M$4.6M$3.1M$4.1M$1.7M$3.5M$12.0M
Deuda a Corto$1.2M$735000$945000$33.6M$360000$52000$43.2M000
Pasivos Corrientes$94.6M$80.2M$61.6M$122.9M$42.1M$34.6M$78.6M$23.0M$21.5M$37.3M
Deuda a Largo$7.6M$7.5M$211.2M$186.3M$171.5M$179.9M000$93.2M
Pasivos Totales$379.8M$300.3M$337.5M$384.1M$247.4M$252.5M$89.7M$32.5M$106.8M$135.7M
Reservas-$729.3M-$847.8M-$1.33B-$1.65B-$1.82B-$1.92B-$1.87B-$1.96B-$2.09B-$2.34B
Patrimonio Neto$560.2M$533.6M$362.9M$71.7M$67.2M$107.3M$126.3M$118.5M$38.5M$20.9M
Deuda Total$8.8M$8.3M$212.3M$232.7M$182.3M$190.1M$51.4M$7.1M$5.5M$98.3M
Deuda Neta-$228.4M-$71.4M-$10.6M$157.6M$82.2M$81.4M-$4.5M-$55.8M-$92.4M$432000
Capital Circulante$220.6M$73.9M$223.9M$111.7M$106.8M$122.0M$39.5M$45.8M$80.9M$77.9M

Balance (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Caja y Equivalentes$14.3M$30.2M$7.5M$16.3M
Activos Totales$171.3M$156.6M$138.6M$170.3M
Pasivos Totales$129.4M$135.7M$118.4M$126.7M
Patrimonio Neto$41.9M$20.9M$20.2M$43.6M
Deuda Total$98.2M$98.3M$98.2M$98.3M

Flujo de Caja (10 años)

Año2016201720182019202020212022202320242025
Beneficio Neto-$190.3M-$126.8M-$514.7M-$170.5M-$170.5M-$92.2M$28.3M-$95.9M-$126.2M-$250.6M
Amortizaciones$24.6M$31.1M$33.1M$17.5M$17.5M$13.8M$10.8M$6.7M$4.5M$3.2M
Compensación en Acciones$53.0M$52.7M$47.0M$18.4M$18.4M$13.9M$10.2M$9.9M$9.5M$10.9M
Cambio en Capital Circulante-$17.7M-$74.6M-$20.0M-$20.7M-$20.7M-$804000-$35.7M$17.1M$4.5M$6.6M
Flujo de Caja Operativo-$56.0M-$104.1M-$124.2M-$77.0M-$77.0M-$55.8M-$65.0M-$66.9M-$68.2M-$87.8M
Inversiones (CapEx)-$31.6M-$46.7M-$41.6M-$7.5M-$7.5M-$7.2M-$4.9M-$1.5M-$8.6M-$2.0M
Adquisiciones-$18.8M-$23.4M-$14.9M-$10.8M000000
Recompra de Acciones-$518000000000000
Dividendos Pagados0000000000
Flujo de Caja Libre-$87.6M-$150.8M-$165.8M-$84.5M-$84.5M-$63.0M-$70.0M-$68.5M-$76.8M-$89.8M

Flujo de Caja (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Flujo de Caja Operativo-$29.1M-$23.5M-$43.8M-$17.8M
Inversiones (CapEx)-$389000-$622000-$258000-$392000
Flujo de Caja Libre-$29.5M-$24.1M-$44.1M-$18.2M
Dividendos Pagados0000
Compensación en Acciones$4.4M$2.2M$3.0M$3.6M

Crecimiento y Márgenes (10 años)

Año2016201720182019202020212022202320242025
Crecimiento Ingresos (anual)+21.0%-30.5%-80.1%+0.0%-55.4%+88.6%-76.9%-36.9%+146.7%
Crecimiento Beneficio Neto (anual)+37.3%-335.3%+66.5%+0.0%+46.0%+130.7%-438.7%-31.6%-98.6%
Crecimiento BPA (anual)+38.0%-301.0%+65.6%+24.4%+53.9%+29.8%-18.2%-20.5%-200.0%
Cambio en Acciones (anual)+1.7%+7.9%+19.0%+8.4%+18.4%+1.3%+22.0%+9.5%+13.8%
Crecimiento FCF (anual)-72.1%-10.0%+49.0%+0.0%+25.5%-11.0%+2.1%-12.1%-17.0%
Margen Bruto67.7%72.8%60.6%83.2%-40.0%-276.2%76.4%1.7%-8.7%37.1%
Margen Operativo-65.6%-59.7%-314.9%-269.8%-269.8%-644.5%-281.4%-1602.5%-3440.2%-1100.8%
Margen EBITDA-88.4%-42.4%-217.4%-215.1%-212.5%-544.2%-232.0%-1433.3%-3146.4%-2515.2%
Margen Neto-97.7%-50.7%-317.2%-533.0%-533.0%-646.0%105.2%-1540.6%-3216.2%-2588.2%
Margen FCF-45.9%-65.3%-103.3%-264.3%-264.3%-441.7%-260.0%-1099.9%-1955.6%-927.6%
Tasa Impositiva Efectiva2.0%2.2%4.0%0.1%0.1%0.1%0.2%0.5%1.4%-0.0%

Datos por Acción (10 años)

Año2016201720182019202020212022202320242025
FCF por Acción$-0.74$-1.26$-1.28$-0.55$-0.51$-0.32$-0.35$-0.28$-0.29$-0.29
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$118.0M$120.0M$129.5M$154.1M$167.1M$197.8M$200.4M$244.5M$267.7M$304.7M

Qué mirar en Biotech

La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.

Ratios Clave (10 años)

Año2016201720182019202020212022202320242025
P/E-15.22-11.76-1.66-4.06-10.00-7.89-4.61-3.44-2.38-2.96
P/VC5.072.592.3311.7825.376.832.412.777.7960.91
P/V14.865.985.2826.4053.2751.4311.3252.6476.40131.52
Margen Bruto67.7%72.8%60.6%83.2%-40.0%-276.2%76.4%1.7%-8.7%37.1%
Margen Operativo-65.6%-59.7%-314.9%-269.8%-269.8%-644.5%-281.4%-1602.5%-3440.2%-1100.8%
Margen Neto-97.7%-50.7%-317.2%-533.0%-533.0%-646.0%105.2%-1540.6%-3216.2%-2588.2%

Empresas relacionadas: AMLX · DNTH · ELVN · IMTX · NKTR · ORIC · RLAY

Explorar sector: Healthcare · Biotechnology

Más secciones de PGEN: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones